Objective: To assess whether streptomycin, an inhibitor of mechano-sensitive cation channels, has an effect on arrhythmias induced by an increase of ventricular wall stress in the rat heart. Methods: The isolated working rat heart preparation was used. Arrhythmias were Ž . Ž . induced by increasing the afterload i.e., aortic pressure against which the left ventricle LV pumped for 20 s. This led to an increase of LV pressure, stretch of the LV and an increase in LV wall stress. The number of ventricular premature beats induced by each afterload step was compared in the absence and presence of streptomycin, a compound known to block mechano-sensitive cation channels in the heart. Results: Perfusion with 200 mM streptomycin caused a significant reduction in wall-stress-induced arrhythmias. The effect of streptomycin on arrhythmias reached steady-state within 10 min of application. In the presence of streptomycin, arrhythmias elicited by a 40 mmHg afterload increase were reduced to 38% of control. Arrhythmias induced by an 80 mmHg afterload increase were reduced to Ž . 61% of control. Complex arrhythmias ventricular tachycardia induced by an afterload increase were also reduced in the presence of 200 mM streptomycin. There was no change in inotropic state with streptomycin, as assessed either by cardiac output or by maximum Ž . developed LV pressure. Streptomycin 50 mM a typical therapeutic plasma concentration in patients had no effect on wall-stress-induced arrhythmias. Conclusions: The results were inconsistent with streptomycin acting by modulating inositol phosphate production, or altering the level of intracellular calcium or inotropic state. The anti-arrhythmic effect of streptomycin appears more consistent with inhibition of mechano-sensitive cation channels, suggesting that these ion channels might be involved in causing wall-stress-induced arrhythmias.
Introduction
An increase of wall stress in the ventricle is known to Ž . induce arrhythmias ventricular ectopic or premature beats w x in the human heart 1-4 and also in the perfused heart of w x experimental animals 5-12 . Arrhythmias induced by a change in ventricular wall stress might be of importance in clinical situations: for instance, hypertensive patients are w x known to have a more labile arterial blood pressure 1,13 . In these patients particularly, but also in normal subjects, a rapid fluctuation in arterial pressure will change the afterload against which the heart pumps, and will lead to ) Ž .
Ž . Corresponding author. Tel.: q44 117 928 8025 direct ; fax: q44 Ž . 117 928 8923; e-mail: allan.levi@bristol.ac.uk alteration of intraventricular pressure and thus ventricular wall stress. Relatively rapid increases in ventricular wall Ž . stress occurring over a few beats may be partly responsi-Ž . ble for the increase in arrhythmias and sudden death w x from which hypertensive patients are known to suffer 14 .
The mechanism by which an increase of wall stress leads to arrhythmia is not known. One possibility is that increased wall stress might cause stretch of ventricular muscle cells, and that this might activate a stretch-sensitive w x cellular mechanism 6,15 . Ventricular muscle cells are known to contain at least two types of stretch-activated ion w x w x channels 16,17 -one type is permeable to cations 18, 19 whilst the other appears to be an anion channel which Ž . w x carries chloride Cl ions 20,21 . In addition, it has also been reported that the L-type Ca channel is sensitive to w x membrane stretch 22 . This gives rise to a distinct possibility that membrane stretch might lead either to a depolarisation of the resting membrane potential, or to an increased influx of Ca or Na ions into the cell, and that these might result in ventricular arrhythmia.
The purpose of this study was to examine whether the aminoglycoside antibiotic, streptomycin, an inhibitor of Ž w x. mechano-sensitive cation channels e.g., Refs. 15,23 , has an effect on wall-stress-induced arrhythmias. We chose the working rat heart preparation for performing these experiments, since in this model ventricular wall stress can be altered in a graded fashion by increasing the aortic afterload against which the heart pumps. This preparation has been shown previously to be a reliable and sensitive model w x of wall-stress-induced arrhythmia 8,10,24 . The results suggest that at least a proportion of the arrhythmias caused by an increase of wall stress might involve mechano-sensitive cation channels.
Methods
Experiments were performed in accordance with the Home Office Guidance on the Operation of the Animals Ž . Scientific Procedures Act 1986, published by HMSO, London.
w x The isolated working heart model 25 including the w x modifications of Taegtmeyer et al. 26 was used to study arrhythmias induced by a step increase of aortic afterload. Experiments were carried out on the hearts of Wistar rats Ž . 250-300 g which were bred in the Animal house at the School of Medical Sciences, University of Bristol.
Preparation of hearts for perfusion
Anaesthesia was induced using 95% O r5% CO with 2 2 4% halothane, and maintained using between 2 and 2.5% w x halothane 10 . The O rCO mixture ensured that the 2 2 animal hyperventilated, thereby achieving optimal tissue Ž . oxygenation. Heparin 500 IU was injected into a femoral vein 2 min before heart removal. The heart was excised and placed immediately in 48C Tyrode's solution, the aorta was mounted on a cannula and retrograde perfusion initiated. The time taken from heart excision to establishment of perfusion was usually less than 60 s. The heart was perfused initially in a Langendorff fashion. The pulmonary veins were identified and cannulated establishing a pathway for solution to pass into the left atrium. Once a tight seal with no leaks had been attained for perfusion into the Ž . left atrium, anterograde 'working heart' perfusion was Ž . commenced at a constant left atrial preload 15 cmH O . 2 The afterload systolic pressure was set by adjusting the height of the aortic column of fluid to achieve a standard systolic pressure of 80 mmHg. This level of afterload pressure was chosen to give a coronary flow rate of close to 18 ml P min y1 -this is similar to the coronary flow rate Ž w x. found in many previous studies e.g., Ref. 27 , and ensured hearts were unlikely to become ischaemic. 
Experimental solutions

Baseline cardiac function tests
All hearts were perfused initially with 6 mM K Tyo rode's solution and allowed to stabilise for a 15 min period prior to the start of the experiment. Baseline cardiac function was then measured. Heart rate in control animals Ž .
mean " s.e.m. was 225 " 10.1 beats P min , and perfusion with 200 mM streptomycin had no significant effect Ž P ) 0.05, non-parametric statistics, see later; n s 6 ani-. mals . Aortic flow was measured using a mechanical flow meter placed in the aortic outflow line. Hearts were ac-Ž cepted only if they could produce a cardiac output s . aortic flow q coronary flow of greater that 50 ml P min , and also if there was a less than 5% decline in cardiac output during each 90 min experiment. Coronary flow was collected and measured from the perfusion chamber overflow cannula. With the standard 80 mmHg aortic afterload, y1 Ž . it was 18.2 " 0.73 ml P min n s 6 hearts . With an imposed increase of afterload by 80 mmHg, coronary flow increased by a further 16.4 " 0.74 ml P min y1 . This suggests that hearts were unlikely to become ischaemic during an increase in afterload. Perfusion with 200 mM strepto-Ž mycin had no significant effect on coronary flow 18.8 " 0.58 ml P min y1 with streptomycin, n s 6 hearts; P ) 0.05 . compared to control hearts . We used two indices to monitor inotropic state. First, we measured cardiac output when the heart was stable in either control or streptomycin solution. Second, we measured the maximum systolic pres-Ž . sure P which could be generated against the crossmax clamped aorta whilst electrically pacing the heart at 300 y1 Ž w x . Ž beats P min e.g., Refs. 8,10,11,28 . This was the only time that hearts were electrically paced. During the normal step increases in aortic afterload, hearts were not electrically paced. With pacing, it was necessary to set a rate faster than intrinsic heart rate, and we were concerned that this may have partially attenuated any arrhythmias nor-. mally observed during an afterload step. Cross-clamping the aorta distal to the pressure transducer prevented out-Ž . flow from the left ventricle LV , and since the ventricle continued to fill during diastole, this will have caused LV Ž . end-diastolic pressure EDP to increase to a standard level ( )in each heart. The level of EDP is expected to determine the maximum systolic pressure which can be produced by Ž . the LV i.e., Frank-Starling relation and thus P might max be expected to reflect the inotropic state of the heart. One caveat to this is that if streptomycin altered passive LV properties, then a given rise in EDP might produce a different end-diastolic volume, and might influence P . max However, there is no evidence for an effect of streptomycin on passive LV properties. By assessing the data obtained from cardiac output and P measurements in max combination, we assumed that were able to detect whether streptomycin altered inotropic state. Baseline cardiac function parameters were recorded at the start of each experiment and monitored at 30 min intervals, when the heart reached a steady state in each perfusate.
Induction of arrhythmias
Following the initial 15 min stabilisation period, the perfusate was changed from 6 mM K Tyrode's to one Ž . increase of aortic pressure afterload; lower trace . ECG shown in upper trace. All traces are from the same heart; however, the two pressure traces were Ž . not obtained simultaneously. First, we placed a needle in the left ventricle see text and measured the change in intra-left-ventricular pressure caused by a step increase of aortic pressure afterload by 80 mmHg. Then we removed the needle from the left ventricle cavity, placed it in the aorta and 20 s later, we made the same step change in afterload and recorded directly the change in aortic pressure.
Other experiments data not shown showed that streptomycin had a significant effect on VPB's within 7.5 Ž . min P -0.05 , and its inhibitory effect on arrhythmias reached steady state within 12.5-15 min. After the test period we removed streptomycin, allowed re-equilibration in normal Tyrode's solution and repeated the afterload steps to obtain post-control data. Fig. 2A ,B illustrates original recordings. The ECG and aortic pressure were recorded routinely, and panel A shows the arrhythmias elicited by an 80 mmHg afterload step during the pre-control period. The heart was initially in sinus rhythm. After a step increase in afterload, it was a consistent finding that VPB's were not observed immediately after the step increase, but took between 3 and 10 s to Ž become evident consistent with intra-LV pressure taking . 3-10 s to reach its maximal level during an afterload step . Once arrhythmias appeared, either they occurred singly with periods of sinus rhythm in between, or else they Ž occurred in runs as VT see latter half of afterload step, . Fig. 2A . Panel B of Fig. 2 shows an identical afterload step applied to the same heart 15 min later, during perfusion with 200 mM streptomycin. Fewer VPB's were elicited by the afterload step-in the presence of streptomycin, the heart remained in sinus rhythm for almost the entire period of the afterload step.
Fig . 2C ,D shows mean data for arrhythmias obtained from control and 200 mM streptomycin-treated hearts. We analysed only the arrhythmias which occurred during the Ž step increase of afterload. Arrhythmias also sometimes occurred at the end of the afterload step, when raised afterload was reduced to 80 mmHg, but these arrhythmias were less reproducible. In addition, we have shown previously that these arrhythmias are always single ectopics and w x never complex arrhythmias 10,11,28 . In contrast, both single and complex arrhythmias occurred reproducibly dur-. ing the increase of afterload. On the basis that complex arrhythmias are potentially more dangerous and thus perhaps more relevant clinically, we confined our analysis of arrhythmias to the period during the afterload increase. Fig. 2C shows arrhythmias elicited by 40 mmHg afterload steps; Fig. 2D shows arrhythmias elicited by 80 mmHg steps. These plots also illustrate one complicating factorthe number of VPB's elicited by a given afterload step declined during the experiment. Thus, it was important that we carried out parallel experiments in control hearts not exposed to streptomycin. For control experiments an identical protocol was performed, except that streptomycin was not added during the 'test' period and hearts remained perfused with 2.4 mM K Tyrode's. In Fig. 2C, comparing o Ž . control hearts n s 6 with those exposed to 200 mM Ž . streptomycin n s 10 hearts , it is clear that streptomycintreated hearts had a similar number of arrhythmias during the pre-and post-control periods, but fewer arrhythmias during streptomycin exposure. The streptomycin-treated hearts developed only 38% of the arrhythmias elicited in control hearts during this period. Using a non-parametric Ž statistical analysis, this difference was significant P -. 0.05 .
A similar picture was observed for 80 mmHg afterload Ž . steps Fig. 2D . Exposure to 200 mM streptomycin reduced arrhythmias to 61% of those observed in control Ž . hearts, and this difference was significant P -0.05 . Therefore, it appears that 200 mM streptomycin inhibited VPB's elicited by an increase in wall stress in the working rat heart.
The effect of 50 mM streptomycin
Streptomycin 200 mM is within the concentration range used experimentally to block mechano-sensitive cation Ž w x . channels e.g., Refs. 15,23,30-33 . However, therapeutic plasma streptomycin concentration in patients is usually near 50 mM, therefore we also tested the effect of this concentration on wall-stress-induced arrhythmias. Fig. 3A ,B illustrates the effect of perfusing 50 mM streptomycin. Panel A shows the pre-control period; as before, VPB's and VT occurred during the 80 mmHg afterload step. Panel B shows an identical afterload step applied to the same heart in the presence of 50 mM streptomycin. VPB's and VT could still be observed.
Mean data for the effect of 50 mM streptomycin on Ž . arrhythmias is shown in Fig. 3C 40 mmHg steps and Fig. Ž . 3D 80 mmHg steps . Once again, it was important to compare the effect of 50 mM streptomycin with data obtained from control hearts not exposed to streptomycin. There was no significant effect of 50 mM streptomycin on the number of VPB's elicited, for afterload steps of either Ž 40 or 80 mmHg P ) 0.05, for arrhythmias elicited in control and streptomycin hearts, for both afterload step . amplitudes . Thus, in contrast to 200 mM, 50 mM streptomycin had no detectable anti-arrhythmic effect.
Does streptomycin affect contractility?
In addition to block of mechano-sensitive cation channels, there are other possible mechanisms for the anti-Ž . Fig. 3 . The effect of 50 mM streptomycin on stretch-induced arrhythmias. A,B Upper panel: During the pre-control period, an 80 mmHg afterload step Ž . elicited ventricular premature beats and ventricular tachycardia. In the presence of 50 mM streptomycin lower panel , arrhythmias could still be elicited in Ž . the same heart. C Mean data for arrhythmias generated in response to a 40 mmHg afterload step. There was no significant difference between control and Ž . Ž . 50 mM streptomycin treated hearts for each of the three experimental periods P ) 0.05 for each point . D Mean data for arrhythmias generated in response to a 80 mmHg afterload step. Once again, there was no significant difference between control and 50 mM streptomycin treated hearts for each of Ž . the 3 experimental periods P ) 0.05 for each point . 3 require consideration. Since these alternative mechanisms might lead to a reduction in inotropic state, we determined the effect of 200 mM streptomycin on inotropic state. We assessed this firstly by measuring cardiac output. Cardiac output in the absence of streptomycin was 58.0 " 4.8 ml P min y1 , and in the presence of streptomycin was 58.7 " 4.8 ml P min y1 ; there was no significant difference. Second, we measured P . Our first choice was to assess max the effect of streptomycin on P when hearts were permax fused with 2.4 mM K solution. However, we found that o Ž . Fig. 4 . A The effect of streptomycin on inotropic state of the heart. The maximal pressure developed by the left ventricle when the aorta was Ž . cross-clamped P was measured every 2.5 min and has been plotted 
Effect of streptomycin on complex arrhythmias
In the clinical situation, it is complex ventricular ar-Ž . rhythmias e.g., VT, and also ventricular fibrillation that are associated with the greatest risk of fatal arrhythmia. We therefore assessed the effect of streptomycin on VT. We counted the number of complexes in each salvo of VT that occurred during each 80 mmHg afterload step, in the Ž . absence and presence of 200 mM streptomycin Fig. 4B . Hearts developed less VT complexes during streptomycin application than did control hearts. The difference in num-Ž . ber of VT complexes was significant P -0.05 . These data show that streptomycin inhibits more complex arrhythmias, in addition to single ventricular ectopics.
Discussion
The results of this study show that in the working rat heart, application of 200 mM streptomycin led to a significant reduction in the number of wall-stress-induced arrhythmias. Streptomycin 200 mM exerted its steady-state anti-arrhythmic effect within 10-15 min of application. Ž We found in this preparation that 50 mM streptomycin a . concentration within the therapeutic range in man had no inhibitory effect on arrhythmias. The data from this study are in agreement with preliminary results from a different study using 80 mM streptomycin on Langendorff-perfused w x guinea-pig hearts 31 , and also with a previous study Ž which used gadolinium Gd; a stretch-activated channel . w x blocker on perfused canine hearts 6 .
Anti-arrhythmic effect of 200 mM streptomycin
Streptomycin 200 mM reduced wall-stress-induced arrhythmias, and it also reduced the incidence of more 15, 19, 23 . We found that a step increase of afterload caused a progressive increase of peak LV systolic pressure over the following 3 to 10 s, and also a small rise of LV EDP. These changes will lead to an increase of LV wall stress, and will result in an increased degree of mechanical stretch of individual ventricular muscle cells. This might be anticipated to open stretch-activated channels in the cell membrane, which will increase the permeability of the membrane both to cations and to Cl ions. This could cause a depolarisation of membrane potential Ž w x. e.g., 36 , and if this reaches threshold and results in opening of TTX-sensitive Na channels, then it might result in an ectopic action potential. An increase in membrane permeability to cations will also increase influx of Ca ions Ž w x. into the cell e.g., 36 . Elevation of intracellular Ca in the rat heart is known to cause spontaneous Ca release from the sarcoplasmic reticulum, leading to transient oscillations Ž of intracellular Ca and generation of arrhythmias e.g., w
x . 7,37-42 .
Streptomycin 200 mM did not abolish arrhythmias completely, but rather inhibited them by between 40 and 60%. One possibility is that this dose of streptomycin might not be maximally effective. The evidence from the present study is consistent with the mechano-sensitive cation channel at least being involved in wall-stress-induced arrhythmia. However, there may be other mechanisms which account for some arrhythmias still present during streptomycin. For instance, with an increase of afterload there was an increase of coronary perfusion and this may lead to a change in cardiac metabolism which may result in arrhythmias. Streptomycin does not inhibit stretch-activated Cl channels, and activation of these by increased wall stress might cause depolarisation. Another possibility is that the L-type Ca channel itself might be sensitive to stretch, since a recent study has reported an increase of L-type Ca channel current in myocytes exposed to mew x chanical and osmotic stresses 22 .
Possible alternatiÕe mechanisms for the antiarrhythmic effect of streptomycin
There are other potential possibilities for the antiarrhythmic effect of streptomycin, in addition to block of the mechano-sensitive cation channel. Streptomycin has been reported previously to reduce L-type Ca channel w x current 34 . However, at least in smooth muscle myocytes, inhibition of the L-type Ca channel by streptomycin occurs w x with a K of 2. least in the ischaemicrreperfused heart, there is evidence w x that IP may be involved in causing arrhythmias 35 . In 3 skeletal muscle IP has been reported to be involved in 3 excitation-contraction coupling and to modulate Ca rew x lease from the sarcoplasmic reticulum 33 and a similar mechanism may also exist in cardiac muscle.
Since both these alternative mechanisms might be expected to cause a reduction in the inotropic state of the heart, we assessed involvement of them by investigating the effect of streptomycin on inotropic state. We found no effect of 200 mM streptomycin on inotropic state, as assessed by measuring both cardiac output and P . This max is consistent with another recent study, which found little effect of 100 mM streptomycin on inotropic state of the w x rabbit heart 30 . These results indicate that streptomycin under these conditions might not cause a reduction of Ca entry via the L-type Ca channel, or a reduction in IP 3 release. With these mechanisms less likely, this would appear to point in the direction that the anti-arrhythmic effect of 200 mM streptomycin might be due to inhibition of the mechano-sensitive cation channel.
Assessment of streptomycin on LV inotropic state
We assessed LV inotropic state using two methodscardiac output and P . Measurement of P has been max max used in previous investigations employing the working rat Ž w x . heart preparation e.g., Refs. 8,10,11,28 . Nevertheless, it is still useful to examine this test more closely. P was max measured by cross-clamping the aortic outflow tube distal to the pressure transducer, whilst electrically pacing at 300 beats P min y1 . This largely prevents outflow from the heart, and any small outflow which does occur will be ejected into the slightly compliant silicon tubes. Diastolic filling of the LV will still occur, so both the end-diastolic volume and pressure must increase. The EDP of the LV will increase up to the maximum level that can be attained, and Ž . that is the preload applied to the left atrium 15 cmH O . 2 According to the Frank-Starling relation, a rise in EDP will lead to increased developed tension by the myocytes in the ventricular wall, and the level of systolic tension and systolic intra-LV pressure will be a measure of inotropic state. We have shown in previous experiments that P max does appear to reflect the inotropic state of the heart. Ž Negatively inotropic agents low external Ca, Ca channel . blockers, low-dose ryanodine lead to a fall in P ; in max Ž contrast, positively inotropic agents high external Ca, low . external Na, isoprenaline, cardiac glycosides, EMD 57033 Ž w x. increase P e.g., 47,48 . One caveat must be added max here-if streptomycin affected passive LV properties, then a given rise in EDP might cause a different amount of diastolic stretch of the ventricle. This would then influence P and make it less reliable as an index of inotropic max state. However, it has not been reported so far that streptomycin might influence passive LV properties. 
Relation to preÕious studies
Some previous studies have investigated the role of stretch-activated channels in causing ventricular arrhythw x mias. Hansen et al. 6 showed in the canine heart that Gd Ž . 1-10 mM inhibited arrhythmias induced by a rapid and brief diastolic stretch. However, Gd is also a potent blocker of the L-type Ca channel in guinea-pig myocytes over an w x identical concentration range 49 . In relation to this, Hansen et al. provided evidence that the anti-arrhythmic effect of Gd under their conditions was not due to inhibition of the Ca channel. One advantage of streptomycin Ž . over Gd might be that it does not at 200 mM block the Ca channel, and thus may be a more selective agent for studying the role of mechano-sensitive cation channels in the rat heart.
Little is known about the dose-response curve for streptomycin on mechano-sensitive cation channels in the w x heart. Gannier et al. 15 found that 40 mM streptomycin inhibited the rise in Ca induced by mechanical stretch of i w x guinea-pig myocytes. In comparison, Nazir et al. 31 in the Langendorff-perfused guinea-pig heart found that 80 mM streptomycin had only a partial inhibitory effect on arrhythmias induced by a brief diastolic stretch of the ventricle. In the working rat heart we found that 50 mM streptomycin had no detectable effect on stretch-induced arrhythmias, whereas 200 mM streptomycin had a partial inhibitory effect. Some of the difference between these studies may reflect a species difference, and it is possible that the mechano-sensitive cation channel in the rat may be less sensitive to streptomycin. It is possible that isolated myocytes might possibly have an altered sensitivity for streptomycin, as evidenced by the apparent higher sensitivity of guinea-pig myocytes to streptomycin, compared to w x the perfused intact guinea-pig heart 15,31 .
Some previous information about streptomycin has come from studies on the cochlea of the ear, where streptomycin inhibits stretch-activated channels in the hair cells, and w x also has a toxic effect on the auditory system. Ohmori 23 found that streptomycin inhibited the stretch-activated channel in doses between 100 and 500 mM, whilst Kroese w x and van den Berken 32 found effects between 20 and 200 mM. The doses used in this study are within the same concentration range, and this is at least consistent with the possibility that in this study, streptomycin acted primarily by inhibiting mechano-sensitive cation channels.
